speb/financial-data huggingface dataset:
Financial scorecard for HLI (Financial Services — Capital Markets, United States)
Report date: 2026-03-31 (annual)
Stock price: 140.23
Market cap: 9684197376 (USD: 9684197376)
P/E ratio: 22.93900481540931
P/B ratio: 3.1622076005684625
Debt to equity: 0.2006
Current ratio: 1.36
Return on net tangible assets (%): 60.084626804145934
Buffett classification: The Great
Analyst consensus upside (%): 18.781051011125886
Rule of 40 score: 27.90393762857773
Altman Z-score: 4.914279816417002 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 1.7971236359897997
Buyback yield (%): 1.8114872424508501
Debt paydown yield (%): -0.556814343061981
Total shareholder yield (%): 3.051796535378669 (Low Return)
Momentum (%): 1m 1.6159420289854998, 3m -10.806513166263839, 6m -24.05220970537262, 12m -27.8726468470322, composite -21.292790351993208 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 8, short score 0, recommendation: Long
Revenue growth 1y (%): -4.6185450060172055
Net income growth 1y (%): -18.114337270341206
Revenue deceleration: no
Accrual ratio: -0.045344306312009516
FCF conversion rate: 2.872569740071117
Beneish M-score: -2.550581547234033 (Likely Safe)
ROE (%): 4.20650313122933
Net margin (%): 15.706143228195701
Asset turnover: 0.15417544395813096
Equity multiplier (leverage): 1.7371465384989735
ROE archetype: Low Return
P/E z-score: 4.358060406665968
FCF z-score: 4.358060406665966
Treasury beta 1y: -0.002689611123195387 (R-squared: 0.0018560390179372746)
Insider 90-day net shares: -6765 (net value USD: -1013079.00)
Dividend increase streak (years): 0
ROIC (%): 28.6477101745871 (pretax: 37.97405018061978)
Incremental ROIC 3y (%): 47.311430903244975 (pretax: 66.89312408852041)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 51.373626373626365, P/B 57.96703296703297, ROIC 8.791208791208792, revenue growth 1y 40.934065934065934, 6m momentum 60.71428571428571
Sector percentiles: P/E 48.42214174857734, 6m momentum 61.69167097775479
Industry median P/E: 0.9254498714652956; industry median ROIC: 1.51204420306575
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.09731930133653044
Base cash flow: 446019000
DCF price per share: base 270.09901820330356, conservative 166.0792215237897, aggressive 450.080473102226
Financial scorecard for HLMA.L (Industrials — Conglomerates, United Kingdom)
Report date: 2026-03-31 (annual)
Stock price: 0.48186666666666667
Market cap: 13649293312 (USD: 17959596463.157894)
P/E ratio: 0.5083243823845327
P/B ratio: 0.06595433344787822
Debt to equity: 0.4213
Current ratio: 2.14
Interest coverage ratio: 15.10919540229885
Return on net tangible assets (%): -522.1835075493611
Buffett classification: The Great
Analyst consensus upside (%): 884571.3153724248
Rule of 40 score: 31.573035717148464
Altman Z-score: 7.441063841307149 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 57.93939393939394, earnings yield % 4.7980306415493565, rank 744
Dividend yield (%): 0.6571768805139441
Buyback yield (%): 0
Debt paydown yield (%): -0.5525998474929249
Total shareholder yield (%): 0.10457703302101917 (Low Return)
Momentum (%): 1m -6.145908081325826, 3m -19.14255479969766, 6m -1.5784340785720739, 12m 10.260152545866823, composite -1.0801998644563884 (Moderate Uptrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 10, short score 2, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): 16.377279995504978
Net income growth 1y (%): 27.260014915832098
Revenue CAGR 3y (%): 14.099356022389408
Net income CAGR 3y (%): 19.162755877260707
FCF CAGR 3y (%): 27.202867620091453
Revenue deceleration: no
Revenue growth consistency score: 1.639083002273623
Beneish M-score: -2.4724345162445975 (Likely Safe)
ROE (%): 18.41823583380663
Net margin (%): 14.417379855167873
Asset turnover: 0.7453621763663439
Equity multiplier (leverage): 1.7139349623374187
ROE archetype: Balanced Compounder
P/E z-score: 4.589436048770873
FCF z-score: 4.589436048770873
Treasury beta 1y: 0.006008991959492028 (R-squared: 0.006782049456063591)
Insider 90-day net shares: 156476 (net value USD: 8120395.00)
Dividend increase streak (years): 0
ROIC (%): 13.57831152978414 (pretax: 17.89652825051055)
Incremental ROIC 3y (%): 18.947788880556505 (pretax: 26.93116812257776)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 44.4043321299639, P/B 2.888086642599278, ROIC 12.996389891696749, revenue growth 1y 9.386281588447654, 6m momentum 43.32129963898917
Sector percentiles: P/E 33.922171018945214, 6m momentum 42.242703533026116
Industry median P/E: 0.1475398300795126; industry median ROIC: 4.422331016216076
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.09498194928472618
Base cash flow: 591578947.368421
DCF price per share: base 0.7129578948138038, conservative 0.38834083662425756, aggressive 1.2963086478484709
Financial scorecard for HLO.AX (Consumer Cyclical — Travel Services, Australia)
Report date: 2025-06-30 (annual)
Stock price: 1.0138888888888888
Market cap: 238973040 (USD: 156191529.4117647)
P/E ratio: 2.757352941176471
P/B ratio: 0.6479835549794873
Debt to equity: 0.1217
Current ratio: 1.26
Return on net tangible assets (%): 56.329651656754464
Buffett classification: The Gruesome
Analyst consensus upside (%): 156.1333333333333
Rule of 40 score: -113.18866704800246
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 9.433700136216203
Buyback yield (%): 0
Debt paydown yield (%): 4.944884159317721
Total shareholder yield (%): 14.378584295533923 (High Return)
Momentum (%): 1m 0.009448223733930432, 3m -5.370370370370372, 6m -22.090643274853797, 12m 9.35515873015873, composite -6.0387286863390885 (Flat)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE (%): 8.686506275754455
Net margin (%): 112.05817237957096
Asset turnover: 0.04386518776788481
Equity multiplier (leverage): 1.7671833456740091
ROE archetype: Standard Business
P/E z-score: 4.984488359108857
Treasury beta 1y: 0.0019390309749984529 (R-squared: 0.00047992378050781104)
Insider 90-day net shares: 2500 (net value USD: 2590.00)
Dividend increase streak (years): 0
ROIC (%): -43.807473117491476 (pretax: -60.18540725025364)
Incremental ROIC 3y (%): -400.5042075973103 (pretax: -572.7901649844957)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 33.75, P/B 15, ROIC 66.25, revenue growth 1y , 6m momentum 60
Sector percentiles: P/E 40.02086230876217, 6m momentum 67.83727399165508
Industry median P/E: 7.453592814371258; industry median ROIC: 12.330112958094723
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.08487881739021366
Base cash flow: 27733333.333333332
DCF price per share: base 1.986748125235741, conservative 1.7927480326336047, aggressive 2.2215864724073375
Financial scorecard for HLVLTD.NS (Consumer Cyclical — Lodging, India)
Report date: 2026-03-31 (annual)
Stock price: 0.07287365813377374
Market cap: 4654374912 (USD: 49325719.71174227)
P/E ratio: 2.0116761623408594
P/B ratio: 0.7970312469996751
Debt to equity: 0.08380000000000001
Current ratio: 1.7531453362255964
Interest coverage ratio: -1.6325878594249201
Return on net tangible assets (%): -2.0795679261732127
Buffett classification: The Gruesome
Rule of 40 score: -7.804842264008775
Altman Z-score: 1.950614302449584 (Grey Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 2.1481697865800955
Total shareholder yield (%): 2.1481697865800955 (Low Return)
Momentum (%): 1m -12.53323100665088, 3m -19.12570793668106, 6m -20.662162440804714, 12m -51.789555415328856, composite -28.22309544201787 (Strong Downtrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 5, short score 5, recommendation: Neutral
Revenue growth 1y (%): -10.412845449356178
Net income growth 1y (%): -92.78385520468872
Revenue CAGR 3y (%): 0.37106537671187656
Net income CAGR 3y (%): -38.144586236106626
FCF CAGR 3y (%): -49.49845782100023
Revenue deceleration: yes
Revenue growth consistency score: 11.9485408599342
Beneish M-score: 4.198726217214459 (Strong Manipulation Signal)
ROE (%): 1.8257860433518032
Net margin (%): 13.55397951142632
Asset turnover: 0.0987717741558866
Equity multiplier (leverage): 1.3637984841729827
ROE archetype: Low Return
P/E z-score: 3.9738532825882484
FCF z-score: 3.9738532825882538
Treasury beta 1y: -0.06907181188200343 (R-squared: 0.0027499180494646464)
Insider 90-day net shares: -19200000 (net value USD: -3016320.00)
Dividend increase streak (years): 0
ROIC (%): -1.445626343781826 (pretax: -1.445626343781826)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 40.77669902912621, P/B 27.184466019417474, ROIC 76.69902912621359, revenue growth 1y 55.33980582524271, 6m momentum 75.72815533980582
Sector percentiles: P/E 38.90820584144645, 6m momentum 66.68984700973574
Industry median P/E: 0.38806260058826786; industry median ROIC: 5.85160871032743
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05
Base cash flow: -1036456.1254768972
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for HQL (Financial Services — Asset Management, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 19.25
Market cap: 585354944 (USD: 585354944)
P/E ratio: 2.371987951807229
P/B ratio: 0.8539657647104445
Debt to equity: 0
Current ratio: 1.61
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 1.9057702488088906, 3m 15.131578947368428, 6m 18.97404202719407, 12m 63.6904761904762, composite 31.57829089174759 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.568948540238796 (Likely Safe)
Equity multiplier (leverage): 1.0038394666417363
ROE archetype: Standard Business
P/E z-score: 4.090429334524002
FCF z-score: 2.0354927539531116
Treasury beta 1y: -0.0005506626302921793 (R-squared: 0.00012324426151495992)
Insider 90-day net shares: 527 (net value USD: 10498.00)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 16.590701914311758, P/B 34.73108477666363, ROIC , revenue growth 1y , 6m momentum 7.292616226071102
Sector percentiles: P/E 18.934299017071908, 6m momentum 13.06259699948267
Industry median P/E: 7.917582417582417; industry median ROIC: 1.6915626385800535
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.08595
Base cash flow: 85594346
DCF price per share: base 45.569951387542105, conservative 40.3906536098021, aggressive 51.82203971608601
Financial scorecard for HR (Real Estate — REIT - Healthcare Facilities, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 21.4
Market cap: 7506092544 (USD: 7506092544)
P/E ratio: 69263.06303119048
P/B ratio: 1.2937698606074122
Debt to equity: 0.9651000000000001
Current ratio: 0.31
Interest coverage ratio: 0.7717836430346786
Return on net tangible assets (%): 1.7943219115285065
Buffett classification: The Gruesome
Analyst consensus upside (%): 27.039904705181648
Rule of 40 score: -4.678485021703534
Altman Z-score: 0.989758951363173 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 1.1177853125067998
Buyback yield (%): 1.3594290158541376
Debt paydown yield (%): -2.5646100000975425
Total shareholder yield (%): -0.0873956717366049 (Minimal or Negative)
Momentum (%): 1m 4.799216454456399, 3m 15.738236884802598, 6m 28.374325134972985, 12m 38.961038961038945, composite 25.569988205726062 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 2, short score 7, recommendation: Neutral
Revenue growth 1y (%): -6.685129625355801
Revenue deceleration: no
Accrual ratio: 0.0009039695735476149
FCF conversion rate: -394.14285714285717
Beneish M-score: -2.5547406801588552 (Likely Safe)
ROE (%): 0.0004578337313579915
Net margin (%): 0.007527151510806839
Asset turnover: 0.030392681528567014
Equity multiplier (leverage): 2.0012811713915832
ROE archetype: Low Return
FCF z-score: 4.713852174607835
Treasury beta 1y: 0.006090038804733459 (R-squared: 0.015363479156103171)
Insider 90-day net shares: -25767 (net value USD: -524874.00)
Dividend increase streak (years): 0
ROIC (%): 0.8524670808854085 (pretax: 1.0790722542853273)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 69.23076923076923, P/B 42.30769230769231, ROIC 84.61538461538461, revenue growth 1y 92.3076923076923, 6m momentum 11.538461538461538
Sector percentiles: P/E 53.649068322981364, 6m momentum 6.832298136645963
Industry median P/E: 25.7741935483871; industry median ROIC: 2.9483185016317277
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.06994561751683627
Base cash flow: 34943000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for HRB (Consumer Cyclical — Personal Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 40.83
Market cap: 5175619584 (USD: 5175619584)
P/E ratio: 5.615384615384616
Debt to equity: -83.11845560479239
Current ratio: 1
Interest coverage ratio: 42.655366766775
Return on net tangible assets (%): -77.15442695872066
Buffett classification: The Great
Analyst consensus upside (%): 25.83625358394393
Rule of 40 score: 1169.727228064392
Altman Z-score: 2.577179872027166 (Grey Zone)
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 155.9957210497571, earnings yield % 16.368214673259605, rank 1
Dividend yield (%): 1.0281860777501843
Buyback yield (%): 0.0007921756870761542
Debt paydown yield (%): 17.568370032661196
Total shareholder yield (%): 18.597348286098455 (High Return)
Momentum (%): 1m 12.386457473162677, 3m 36.418309388573334, 6m 4.4779938587512795, 12m -24.234551864910006, composite 2.7704693635079045 (Strong Downtrend)
Lynch category: Stalwart (confidence: High)
Screener: long score 10, short score 5, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): 5.3138987064271115
Net income growth 1y (%): 17.384159594645098
Revenue deceleration: no
Accrual ratio: -0.21867280591635704
FCF conversion rate: 1.8151836122377494
Beneish M-score: 5.038746779057767 (Strong Manipulation Signal)
Net margin (%): 35.357096242995
Asset turnover: 0.7586871817325895
ROE archetype: Standard Business
P/E z-score: 5.1381563131394925
FCF z-score: 5.138156313139494
Treasury beta 1y: -0.0021617136489312304 (R-squared: 0.0005066777302318473)
Insider 90-day net shares: -305267 (net value USD: -13936294.00)
Dividend increase streak (years): 0
ROIC (%): 57.10394039246787 (pretax: 73.21550633275177)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 49.36708860759494, P/B , ROIC 1.2658227848101267, revenue growth 1y 16.455696202531644, 6m momentum 17.72151898734177
Sector percentiles: P/E 42.59388038942976, 6m momentum 26.35605006954103
Industry median P/E: 0.17977747862805335; industry median ROIC: 6.5091735771840575
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05901380189198641
Base cash flow: 640566000
DCF price per share: base 147.80594752736764, conservative 117.38922210542096, aggressive 190.30073049992504
Financial scorecard for HRI (Industrials — Rental & Leasing Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 162.59
Market cap: 5429376000 (USD: 5429376000)
P/B ratio: 1.7424909225711276
Debt to equity: 5.0806000000000004
Current ratio: 1.46
Interest coverage ratio: 0.8359375
Buffett classification: The Gruesome
Analyst consensus upside (%): 76.52463651050081
Rule of 40 score: -9.47735414302012
Altman Z-score: 0.46659724515580436 (Distress Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 1.2732032365540218, earnings yield % 0.7119390718550125, rank 2333
Dividend yield (%): 0.4420397482141594
Buyback yield (%): 0
Debt paydown yield (%): 0.7367329136902657
Total shareholder yield (%): 1.1787726619044252 (Low Return)
Momentum (%): 1m 13.51672135725757, 3m 33.45645571698269, 6m 2.813962311875564, 12m 12.64375779409727, composite 11.833800143839541 (Moderate Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 8, recommendation: Short
Revenue growth 1y (%): 32.28803716608595
Revenue deceleration: no
Accrual ratio: 0.0008778346744696416
FCF conversion rate: 1.5
Beneish M-score: -2.459570170716175 (Likely Safe)
ROE (%): -1.24804992199688
Net margin (%): -2.1071115013169446
Asset turnover: 0.08332114118507682
Equity multiplier (leverage): 7.108684347373895
ROE archetype: Low Return
P/E z-score: 5.082134275250043
Treasury beta 1y: 0.009361125305689675 (R-squared: 0.004487079297120078)
Insider 90-day net shares: 3000 (net value USD: 427410.00)
Dividend increase streak (years): 0
ROIC (%): 5.371793764573797 (pretax: 5.371793764573797)
Incremental ROIC 3y (%): 2.850686308448274 (pretax: 0.911854103343465)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 51.92307692307693, ROIC 38.46153846153847, revenue growth 1y 5.769230769230769, 6m momentum 30.76923076923077
Sector percentiles: P/E , 6m momentum 34.4342037890425
Industry median P/E: 1.3202365863962822; industry median ROIC: 4.993191103041307
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.07905978584920079
Base cash flow: 452000000
DCF price per share: base 392.0611424769018, conservative 83.41049372766145, aggressive 964.241057373931
Financial scorecard for HRS.DE (Industrials — Aerospace & Defense, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 300.45454545454544
Market cap: 49256382464 (USD: 49256382464)
P/E ratio: 42.338348748987684
P/B ratio: 3.2423390599295625
Debt to equity: 0.3457
Current ratio: 1.0340658063015928
Interest coverage ratio: 4.720588235294118
Return on net tangible assets (%): -11.834586466165414
Buffett classification: The Great
Rule of 40 score: -3.1227066844476705
Altman Z-score: 1.710008824379408 (Distress Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 21.755337173839376, earnings yield % 0.9797563837229138, rank 603
Dividend yield (%): 0.4831861133406356
Buyback yield (%): 0.6009373510454964
Debt paydown yield (%): -0.48927669460123185
Total shareholder yield (%): 0.5948467697849 (Low Return)
Momentum (%): 1m 2.282398452611213, 3m -4.936937901140838, 6m -14.916589939910851, 12m , composite -9.926763920525845 (Moderate Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): 11.925175370226038
Net income growth 1y (%): 32.64248704663213
Revenue deceleration: no
Accrual ratio: 0.01709960641840751
FCF conversion rate: -0.37890625
Beneish M-score: -2.21487081985306 (Likely Safe)
ROE (%): 2.6046038407732417
Net margin (%): 8.913649025069638
Asset turnover: 0.1391220102936724
Equity multiplier (leverage): 2.1003433803891642
ROE archetype: Low Return
P/E z-score: 4.052893195945133
FCF z-score: 4.05289319594513
Treasury beta 1y: 0.04280937252354421 (R-squared: 0.002053088181190121)
Insider 90-day net shares: -2180 (net value USD: -676781.00)
Dividend increase streak (years): 1
ROIC (%): 6.021209220776811 (pretax: 7.24344720706152)
Incremental ROIC 3y (%): 3.667745102935239 (pretax: 4.51665644798692)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 35.585585585585584, P/B 30.180180180180184, ROIC 41.891891891891895, revenue growth 1y 36.93693693693694, 6m momentum 39.189189189189186
Sector percentiles: P/E 62.59600614439324, 6m momentum 63.49206349206349
Industry median P/E: 27.773289779307788; industry median ROIC: 6.974431518937386
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.08083186472998832
Base cash flow: 2406000000
DCF price per share: base 327.921464947021, conservative 204.62753854950697, aggressive 517.5086054543459
Financial scorecard for HRTG (Financial Services — Insurance - Property & Casualty, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 27.82
Market cap: 842209408 (USD: 842209408)
P/E ratio: 4.0260736196319025
P/B ratio: 1.5271383380543149
Debt to equity: 0.19030000000000002
Current ratio: 0.77
Return on net tangible assets (%): 7.691024934465935
Buffett classification: The Gruesome
Analyst consensus upside (%): 27.61904761904762
Rule of 40 score: 69.28015115034972
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.188065569554882
Debt paydown yield (%): 0.09106998719254393
Total shareholder yield (%): 1.279135556747426 (Low Return)
Momentum (%): 1m 8.927173061863748, 3m -4.953877690468054, 6m 9.140839544919583, 12m 29.455560725919046, composite 7.677645575495013 (Moderate Uptrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 1, recommendation: Neutral
Revenue growth 1y (%): -1.585830590680759
Net income growth 1y (%): 19.718448513486898
Revenue deceleration: no
Accrual ratio: 0.006372121458753379
FCF conversion rate: 0.631746292793904
Beneish M-score: -2.9094244336354094 (Likely Safe)
ROE (%): 7.114310033998847
Net margin (%): 16.053560270705542
Asset turnover: 0.10778679408063828
Equity multiplier (leverage): 4.111458108876263
ROE archetype: Standard Business
P/E z-score: 4.2732151555851825
FCF z-score: 4.273215155585182
Treasury beta 1y: -0.0044291188616230985 (R-squared: 0.0011532977551159042)
Insider 90-day net shares: -78758 (net value USD: -2119142.00)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 22.22222222222222, P/B 41.66666666666667, ROIC , revenue growth 1y 58.333333333333336, 6m momentum 59.72222222222222
Sector percentiles: P/E 21.546818416968446, 6m momentum 22.943610967408173
Industry median P/E: 8.869425040300914; industry median ROIC: 35.8357333390367
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.09168576394730084
Base cash flow: 203403000
DCF price per share: base 146.26195965986525, conservative 118.91272161992258, aggressive 182.74868757438898
Financial scorecard for HUBTOWN.NS (Real Estate — Real Estate - Development, India)
Report date: 2026-03-31 (annual)
Stock price: 2.012592898431049
Market cap: 27706785792 (USD: 293628505.6379822)
P/E ratio: 0.17074744762193259
P/B ratio: 0.913310165953031
Debt to equity: 0.4493
Current ratio: 1.96
Interest coverage ratio: 0.9930306650736758
Return on net tangible assets (%): 6.409010461110584
Buffett classification: The Great
Rule of 40 score: 71.13088527350635
Altman Z-score: 0.9981992379355623 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -10.607778210524408, 3m -7.358709869725594, 6m -8.902014148533304, 12m -43.136682006395475, composite -17.549896151549603 (Strong Downtrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 2, short score 6, recommendation: Neutral
Revenue growth 1y (%): 49.916806600265296
Net income growth 1y (%): 573.3475676902516
Revenue deceleration: no
Accrual ratio: -0.0030442089840918207
FCF conversion rate: 1.1142979452054795
Beneish M-score: -2.359452815327393 (Likely Safe)
ROE (%): 6.068532110178461
Net margin (%): 25.410638529315783
Asset turnover: 0.10481428161331861
Equity multiplier (leverage): 2.2784925549840307
ROE archetype: Standard Business
P/E z-score: 3.431806822447389
FCF z-score: 2.5185845993662634
Treasury beta 1y: 0.0003655670237428439 (R-squared: 1.091108165374458e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 4.115800263591466 (pretax: 4.612154805137152)
Incremental ROIC 3y (%): 9.250202710900336 (pretax: 8.76472430194512)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 16.412213740458014, P/B 55.343511450381676, ROIC 28.62595419847328, revenue growth 1y 8.396946564885496, 6m momentum 44.274809160305345
Sector percentiles: P/E 12.422360248447205, 6m momentum 49.378881987577635
Industry median P/E: 0.7477477477477478; industry median ROIC: 1.4222722989118621
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.06690785064406206
Base cash flow: 17192666.384061042
DCF price per share: base 0.07170556590573182, conservative 0.035698617914973356, aggressive 0.141452452749695
Financial scorecard for HUM (Healthcare — Healthcare Plans, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 387
Market cap: 46742343680 (USD: 46742343680)
P/E ratio: 18.441364605543708
P/B ratio: 1.1138173479566662
Debt to equity: 0.7706999999999999
Current ratio: 1.77
Return on net tangible assets (%): 15.560499320232356
Buffett classification: The Gruesome
Analyst consensus upside (%): 101.15620302925194
Rule of 40 score: 24.666582611589092
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0.22891449502944564
Buyback yield (%): 0.22891449502944564
Debt paydown yield (%): -3.4743657937179413
Total shareholder yield (%): -3.01653680365905 (Minimal or Negative)
Momentum (%): 1m 7.264613764239579, 3m 80.23472429210135, 6m 46.29720636600766, 12m 71.2768311573357, composite 62.06961677686764 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 0, recommendation: Neutral
Revenue growth 1y (%): 23.467862481315404
Net income growth 1y (%): -4.662379421221862
Revenue deceleration: no
Accrual ratio: 0.0010173818733263589
FCF conversion rate: 0.9553119730185498
Beneish M-score: -2.0135794873405355 (Likely Safe)
ROE (%): 6.519528351153012
Net margin (%): 2.991323648103309
Asset turnover: 0.761078424785726
Equity multiplier (leverage): 2.863672594343512
ROE archetype: Standard Business
P/E z-score: 4.682866959535288
FCF z-score: 4.682866959535286
Treasury beta 1y: -0.0031669643163919742 (R-squared: 0.0007690442872067993)
Insider 90-day net shares: 810 (net value USD: 150016.00)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 42.10526315789473, P/B 10.526315789473683, ROIC , revenue growth 1y 15.789473684210526, 6m momentum 10.526315789473683
Sector percentiles: P/E 22.636103151862464, 6m momentum 7.163323782234957
Industry median P/E: 18.91807118149876; industry median ROIC: 10.186006764918668
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07390214124228457
Base cash flow: 1504000000
DCF price per share: base 611.3393432851527, conservative 384.56644759523937, aggressive 1008.8398621699201
Financial scorecard for HVT (Consumer Cyclical — Home Improvement Retail, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 24.91
Market cap: 400935232 (USD: 400935232)
P/E ratio: 17.114754098360656
P/B ratio: 1.0136840222953514
Debt to equity: 0.715
Current ratio: 1.84
Return on net tangible assets (%): 3.432036032627662
Buffett classification: The Great
Analyst consensus upside (%): 41.283524904214566
Rule of 40 score: -12.84306473462766
Altman Z-score: 2.1283321892209566 (Grey Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 1.0241610793911424, earnings yield % 0.9634940153212868, rank 2189
Dividend yield (%): 1.3241540219643255
Buyback yield (%): 0.4963395184985888
Debt paydown yield (%): -0.7036049154193563
Total shareholder yield (%): 1.1168886250435581 (Low Return)
Momentum (%): 1m -2.044828942194257, 3m 11.255024564537738, 6m -2.39028213166144, 12m 24.177467597208384, composite 11.878144453364882 (Strong Uptrend)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 2, short score 7, recommendation: Neutral
Revenue growth 1y (%): 4.1213436362334654
Net income growth 1y (%): 12.784542085759654
Revenue deceleration: no
Accrual ratio: 0.021777346838497278
FCF conversion rate: -2.312837362121568
Beneish M-score: -2.4751593312236073 (Likely Safe)
ROE (%): 1.386728284570573
Net margin (%): 2.2539010843692147
Asset turnover: 0.2916553853653946
Equity multiplier (leverage): 2.109533960360595
ROE archetype: Low Return
P/E z-score: 4.595346179572692
FCF z-score: 4.595346179572694
Treasury beta 1y: -0.005847700470905103 (R-squared: 0.006020458023892887)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 3.901062963592362 (pretax: 5.305485174965729)
Incremental ROIC 3y (%): -633.5831620673654 (pretax: -844.2282523340023)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 56.75675675675676, P/B 48.64864864864865, ROIC 59.45945945945946, revenue growth 1y 18.91891891891892, 6m momentum 27.027027027027028
Sector percentiles: P/E 51.91237830319889, 6m momentum 38.108484005563284
Industry median P/E: 0.40370098339250005; industry median ROIC: 5.090664474932048
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.08634377550983928
Base cash flow: 43441000
DCF price per share: base 40.8229009591632, conservative 35.50983163026547, aggressive 47.230047931271635
Financial scorecard for IC2.DE (Financial Services — Financial Data & Stock Exchanges, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 143.52272727272728
Market cap: 71424229376 (USD: 71424229376)
P/E ratio: 25.97434726345437
P/B ratio: 3.0011656951083525
Debt to equity: 0.7099
Current ratio: 1.01
Interest coverage ratio: 8.403940886699507
Return on net tangible assets (%): -10.083620265617315
Buffett classification: The Great
Rule of 40 score: 45.918955926133904
Altman Z-score: 0.5147136248797068 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0.4158252774930157
Buyback yield (%): 0.9044549806750442
Debt paydown yield (%): -0.9884600872392898
Total shareholder yield (%): 0.3318201709287699 (Low Return)
Momentum (%): 1m 8.691910499139407, 3m -8.887912117409416, 6m -16.533717719062548, 12m 19.356538677055266, composite -5.203278052448104 (Flat)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 4, short score 4, recommendation: Neutral
Revenue growth 1y (%): 13.533601734283064
Net income growth 1y (%): 76.35467980295567
Revenue deceleration: no
Accrual ratio: 0.0017844487192467348
FCF conversion rate: 0.803072625698324
Beneish M-score: -2.55355664359089 (Likely Safe)
ROE (%): 4.891295066008573
Net margin (%): 39.06164757228587
Asset turnover: 0.02319783335020755
Equity multiplier (leverage): 5.397913001895718
ROE archetype: Low Return
P/E z-score: 4.881011901358967
FCF z-score: 4.88101190135897
Treasury beta 1y: 0.042347423372693184 (R-squared: 0.0018198936329786573)
Insider 90-day net shares: -29974 (net value USD: -4388929.00)
Dividend increase streak (years): 1
ROIC (%): 8.490719254055863 (pretax: 10.949752486091032)
Incremental ROIC 3y (%): 8.789418815502083 (pretax: 14.1961486789073)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 58.139534883720934, P/B 23.25581395348837, ROIC 51.162790697674424, revenue growth 1y 30.23255813953488, 6m momentum 65.11627906976744
Sector percentiles: P/E 49.66373512674599, 6m momentum 58.380755302638384
Industry median P/E: 19.132963988919666; industry median ROIC: 11.257628306763747
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.08681562568996908
Base cash flow: 4139000000
DCF price per share: base 177.12137843210948, conservative 107.75982303924806, aggressive 285.36544900662085
Financial scorecard for ICCC (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 10.15
Market cap: 99786192 (USD: 99786192)
P/E ratio: 7.373561909026904
P/B ratio: 1.965545187856272
Debt to equity: 0.4386
Current ratio: 4.82
Interest coverage ratio: 20.403825232860534
Return on net tangible assets (%): 7.929449019460849
Buffett classification: The Great
Rule of 40 score: 67.27024368182624
Altman Z-score: 4.3664627980436945 (Safe Zone)
Piotroski F-score: 9 (Strong)
Magic formula: return on capital % 4.915230619234407, earnings yield % 1.8622208696100806, rank 884
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.41789348971248447
Total shareholder yield (%): 0.41789348971248447 (Low Return)
Momentum (%): 1m 3.677221654749757, 3m 21.41148325358853, 6m 62.14057507987222, 12m 50.14792899408285, composite 42.79151451352044 (Strong Uptrend)
Lynch category: Fast Grower (confidence: High)
Screener: long score 8, short score 0, recommendation: Long
Revenue growth 1y (%): 28.38814434893806
Net income growth 1y (%): 34.18312447347343
Revenue deceleration: no
Accrual ratio: -0.033568333799607
FCF conversion rate: 1.7489641312582824
Beneish M-score: -2.725909146245398 (Likely Safe)
ROE (%): 6.910799188190464
Net margin (%): 18.74627496851253
Asset turnover: 0.23908579998335888
Equity multiplier (leverage): 1.54191171393324
ROE archetype: Standard Business
FCF z-score: 1.5036097167368894
Treasury beta 1y: 0.008096827280071233 (R-squared: 0.004229312781240946)
Insider 90-day net shares: 8000 (net value USD: 75960.00)
Dividend increase streak (years): 0
ROIC (%): 3.575308756546142 (pretax: 4.525707286767268)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 7.490974729241877, P/B 23.465703971119133, ROIC 8.12274368231047, revenue growth 1y 11.462093862815886, 6m momentum 6.137184115523466
Sector percentiles: P/E 18.83954154727794, 6m momentum 4.548710601719198
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06828922394728532
Base cash flow: 475267
DCF price per share: base 2.1552185928408765, conservative 0.6322821493408466, aggressive 5.114796559579239
Financial scorecard for IGC (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.26
Market cap: 27552668 (USD: 27552668)
P/B ratio: 4.43313252736481
Debt to equity: 0.15130000000000002
Current ratio: 1.32
Return on net tangible assets (%): -274.9120750293083
Buffett classification: The Gruesome
Rule of 40 score: -767.1572780531772
Altman Z-score: -15.080823692704785 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.8454594669380113
Total shareholder yield (%): -2.8454594669380113 (Minimal or Negative)
Momentum (%): 1m -3.703703703703707, 3m -23.529411764705884, 6m -10.344827586206886, 12m -29.729729729729726, composite -20.30042212597993 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -3.9393939393939426
Revenue deceleration: no
Accrual ratio: -0.10678943747684817
FCF conversion rate: 0.5799333888426311
Beneish M-score: -2.967373845826401 (Likely Safe)
ROE (%): -35.4695806261075
Net margin (%): -757.7287066246057
Asset turnover: 0.03355029898925756
Equity multiplier (leverage): 1.395230360307147
ROE archetype: Low Return
Treasury beta 1y: 0.0072449255218847985 (R-squared: 0.003228641151665371)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): -95.44604900210936 (pretax: -120.81778354697389)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 42.87003610108303, ROIC 24.638989169675092, revenue growth 1y 19.584837545126355, 6m momentum 35.37906137184115
Sector percentiles: P/E , 6m momentum 40.54441260744986
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07204368704924348
Base cash flow: -6735000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for IGI (Financial Services — Asset Management, United States)
Report date: 2025-11-30 (annual)
Stock price: 15.84
Market cap: 94909464 (USD: 94909464)
P/E ratio: 16
P/B ratio: 0.9030613225500048
Debt to equity: 0
Return on net tangible assets (%): 5.648689140361396
Buffett classification: The Gruesome
Rule of 40 score: -63.09498559614968
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -0.6273525721455435, 3m -0.6273525721455435, 6m -1.6149068322981464, 12m 1.4734144778987857, composite -0.04274331205137708 (Flat)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -1.363683137202862 (Strong Manipulation Signal)
ROE (%): 5.672510491068376
Net margin (%): 95.39099253425042
Asset turnover: 0.058685438988140826
Equity multiplier (leverage): 1.0132989264961647
ROE archetype: Standard Business
P/E z-score: 3.809834461560519
Treasury beta 1y: -3.250457460218988e-05 (R-squared: 5.527692571068409e-06)
Insider 90-day net shares: 700 (net value USD: 11410.00)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E 50.95715587967183, P/B 47.493163172288064, ROIC , revenue growth 1y , 6m momentum 46.672743846855056
Sector percentiles: P/E 44.2058975685463, 6m momentum 44.2058975685463
Industry median P/E: 7.917582417582417; industry median ROIC: 1.6915626385800535
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.1019
Base cash flow: 5998488
DCF price per share: base 12.916681285802664, conservative 11.660391328505394, aggressive 14.38501164010074
Financial scorecard for IGN.AX (Industrials — Staffing & Employment Services, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.513888888888889
Market cap: 12239753 (USD: 7999838.562091503)
P/E ratio: 14.640522875816995
P/B ratio: 2.1794153788235295
Debt to equity: 0.0006
Current ratio: 5.11
Interest coverage ratio: 16.5
Return on net tangible assets (%): 16.376470588235296
Buffett classification: The Great
Rule of 40 score: -6.411565745179345
Altman Z-score: 6.145360145908421 (Safe Zone)
Piotroski F-score: 0 (Weak)
Dividend yield (%): 4.673296920289159
Buyback yield (%): 0
Debt paydown yield (%): 1.9368037900764825
Total shareholder yield (%): 6.610100710365642 (Moderate Return)
Momentum (%): 1m 4.9491392801252125, 3m 19.907407407407412, 6m 2.77777777777779, 12m -46.113040123456784, composite -8.656343124733926 (Strong Downtrend)
Lynch category:  (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): -8.536770945055117
Net income growth 1y (%): 96.55589508530684
Revenue CAGR 3y (%): -9.565216672204425
Revenue deceleration: no
Revenue growth consistency score: 1.6020650472783222
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 1.5758823529411765
ROE archetype: Standard Business
P/E z-score: 3.6547949965794357
FCF z-score: 4.505643724974119
Treasury beta 1y: 0.0023238357151156522 (R-squared: 0.000455786064738191)
Insider 90-day net shares: 23812 (net value USD: 23897.00)
Dividend increase streak (years): 0
ROIC (%): 36.09375 (pretax: 36.09375)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 61.111111111111114, P/B 55.55555555555556, ROIC 23.015873015873016, revenue growth 1y 23.809523809523807, 6m momentum 28.57142857142857
Sector percentiles: P/E 50.64004096262161, 6m momentum 34.485407066052225
Industry median P/E: 0.15202702702702706; industry median ROIC: 17.191501638800393
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05
Base cash flow: 909803.9215686275
DCF price per share: base 2.367769269276403, conservative 1.9247127152123973, aggressive 3.0422205290772064
Financial scorecard for IGPL.NS (Basic Materials — Chemicals, India)
Report date: 2026-03-31 (annual)
Stock price: 4.660920726672172
Market cap: 13905414144 (USD: 147365558.9656634)
P/E ratio: 4.855542660195541
P/B ratio: 0.7621537752069563
Debt to equity: 0.27140000000000003
Current ratio: 1.37
Interest coverage ratio: 1.6979727307533792
Return on net tangible assets (%): -6.85096161074536
Buffett classification: The Gruesome
Analyst consensus upside (%): 14230.701674966047
Rule of 40 score: -24.12167635186604
Altman Z-score: 2.632248247586439 (Grey Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 3.336721356148266, earnings yield % 0.03155996522099408, rank 2413
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -0.2638411050680347, 3m 3.221378888602929, 6m 15.323308129740324, 12m -17.089713865377337, composite 0.5581010836910553 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): -20.955472600744518
Net income growth 1y (%): -98.1491067688691
Revenue CAGR 3y (%): -10.75238111795882
Net income CAGR 3y (%): -78.70712671082502
Revenue deceleration: yes
Revenue growth consistency score: 11.839548113376237
Beneish M-score: 3.846197109282084 (Strong Manipulation Signal)
ROE (%): 2.1056756377373316
Net margin (%): 5.353366885776096
Asset turnover: 0.227898559859507
Equity multiplier (leverage): 1.72592883078482
ROE archetype: Low Return
P/E z-score: 4.463952190397081
Treasury beta 1y: 0.04747966744816788 (R-squared: 0.0016844167910024896)
Insider 90-day net shares: 0 (net value USD: )
Dividend increase streak (years): 1
ROIC (%): 3.048115417788109 (pretax: 4.689408335058629)
Incremental ROIC 3y (%): -259.2192658956743 (pretax: -335.54171415851044)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 55.3030303030303, P/B 21.21212121212121, ROIC 59.84848484848485, revenue growth 1y 63.63636363636363, 6m momentum 22.727272727272727
Sector percentiles: P/E 22.2376457523598, 6m momentum 12.43753470294281
Industry median P/E: 0.21362271362271362; industry median ROIC: 4.746285835859994
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05520097280227877
Base cash flow: -9658043.662568886
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for IMU.AX (Healthcare — Biotechnology, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.0625
Market cap: 44827908 (USD: 29299286.274509802)
P/B ratio: 4.8666953115664695
Debt to equity: 0.1189
Current ratio: 1.78
Return on net tangible assets (%): -563.7088235748365
Buffett classification: The Gruesome
Analyst consensus upside (%): 7.795454545454553
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -9.374999999999998, 3m -32.69230769230769, 6m -73.92857142857143, 12m -66.29464285714286, composite -56.47625363142604 (Strong Downtrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.17650646188267002
FCF conversion rate: 1.3043315766082078
Beneish M-score: -2.366827121843721 (Likely Safe)
ROE (%): -83.33335378788172
Equity multiplier (leverage): 1.4368296022597702
ROE archetype: Low Return
Treasury beta 1y: -0.01615735649287962 (R-squared: 0.004517051347760128)
Insider 90-day net shares: 245053 (net value USD: 20198.00)
Dividend increase streak (years): 0
ROIC (%): -201.2261152884478 (pretax: -254.71660163094657)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 45.48736462093863, ROIC 31.046931407942242, revenue growth 1y , 6m momentum 74.63898916967509
Sector percentiles: P/E , 6m momentum 77.18481375358166
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.14957830385519616
Base cash flow: -49142713.07189543
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for IMUX (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 13.39
Market cap: 182391664 (USD: 182391664)
P/B ratio: 0.9997716192894408
Debt to equity: 0.0028000000000000004
Current ratio: 4.92
Return on net tangible assets (%): -21.527708899512675
Buffett classification: The Gruesome
Analyst consensus upside (%): 289.36936936936934
Rule of 40 score: 0
Altman Z-score: -1.5158134851256735 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.08553022467079417
Total shareholder yield (%): 0.08553022467079417 (Low Return)
Momentum (%): 1m -8.973487423521416, 3m 52.1590909090909, 6m 94.90538573508006, 12m 25.140186915887863, composite 61.513704052729885 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.1429881100498611
FCF conversion rate: 0.5309623174174543
Beneish M-score: -2.5914894894960434 (Likely Safe)
ROE (%): -45.085777531820696
Asset turnover: 0
Equity multiplier (leverage): 1.4789291643608191
ROE archetype: Low Return
Treasury beta 1y: -0.0008242885284038794 (R-squared: 1.953279380910578e-05)
Insider 90-day net shares: 363099 (net value USD: 268362.00)
Dividend increase streak (years): 0
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 11.462093862815886, ROIC , revenue growth 1y , 6m momentum 3.3393501805054155
Sector percentiles: P/E , 6m momentum 2.4713467048710602
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.12224949632317061
Base cash flow: -97165000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for INAB (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.2
Market cap: 11507595 (USD: 11507595)
P/B ratio: 0.6230060032483209
Debt to equity: 0.1033
Current ratio: 10.5
Return on net tangible assets (%): -20.1878758614635
Buffett classification: The Gruesome
Analyst consensus upside (%): 322.2972972972973
Rule of 40 score: 0
Altman Z-score: -5.5351867818465985 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 3.719282786716078
Total shareholder yield (%): 3.719282786716078 (Low Return)
Momentum (%): 1m -18.91891891891892, 3m -20.000000000000004, 6m -50, 12m -50.20746887966805, composite -36.19640387275242 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.004577518916426119
FCF conversion rate: 0.9736738703339882
Beneish M-score: -2.453040537831692 (Likely Safe)
ROE (%): -20.22288881384215
Asset turnover: 0
Equity multiplier (leverage): 1.1630544905540436
ROE archetype: Low Return
Treasury beta 1y: 0.0036305180974093216 (R-squared: 0.000380139847935834)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): -483.07235221674875 (pretax: -611.4839901477833)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 6.949458483754513, ROIC 37.81588447653429, revenue growth 1y , 6m momentum 66.69675090252709
Sector percentiles: P/E , 6m momentum 70.55873925501433
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05832175689912883
Base cash flow: -16939000
DCF price per share: base 0, conservative 0, aggressive 0